This inventor holds 5 USPTO granted patents. Top assignees: Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu, Spofa Spojene Podniky Pro Zdravotnickou, Spofa, Spojene Podinky Pro Zdravotnickou Vyrobu. Active years: 1981-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Prague, CZ (1981 - 1988)
- Praha, CZ (1989 - 1995)
Company Filing History:
2 out of 16 
1 out of 2 
1 out of 1 Years Active: 1981-1995
Title: Miroslav Rajsner: Innovator in Pharmaceutical Chemistry
Introduction
Miroslav Rajsner is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 5 patents, Rajsner has focused on developing compounds that have potential therapeutic applications.
Latest Patents
Among his latest patents are the N-arylalkylderivatives of 2-aminomethyl-2,3-dihydro-1,4-benzodioxine and 2-Isopropyl-2-(2-methylphenyl)-5-(N-methyl-N-homoveratrylamino)-valeronitrile, commonly known as 'mepamil'. The formula for this compound is designed to be preferably administered in the form of water-soluble acid addition salts, such as hydrochloride. The preparation of this compound involves the alkylation of 2-(2-methylphenyl)-3-methylbutyronitrile with 3,3-diethoxypropylchloride, followed by mild acidic hydrolysis to yield the appropriate aldehyde. This aldehyde is then reacted with N-methylhomoveratrylamine under conditions of reductive alkylation, which can be achieved through catalytic hydrogenation or chemical reduction using formic acid.
Career Highlights
Throughout his career, Miroslav Rajsner has worked with several prominent companies in the pharmaceutical industry. Notable among these are Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu, and Spofa Spojene Podniky Pro Zdravotnickou. His work in these organizations has contributed to advancements in medical products and therapies.
Collaborations
Miroslav has collaborated with several professionals in his field, including Vaclav Trcka and Ivan Helfert. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceutical chemistry.
Conclusion
Miroslav Rajsner's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field positively, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile